Endowment Sells $95M of Eli Lilly Shares, Boosting Ventyx Acquisition Momentum
Investor insight: LILLY ENDOWMENT INC sold $95 M of Eli Lilly shares on Jan 7, 2026, sparking brief volatility but underscoring portfolio realignment amid the Ventyx acquisition and Eli Lilly’s robust, diversified pipeline.
3 minutes to read